An open label, dose escalation phase I study of the safety, pharmaccodynamics and pharmacokinetics of ATN-224 capsules in patients with advanced hematological malignancies
Phase of Trial: Phase I
Latest Information Update: 18 Jan 2006
At a glance
- Drugs Bis-choline tetrathiomolybdate (Primary)
- Indications Haematological malignancies
- Focus Adverse reactions
- 18 Jan 2006 New trial record.